Ibuprofen PM
- Product NDC
- 21130-056
- Requested package NDC
- 21130-056-40
- 11-digit product format
- 211300056
- Labeler code
- 21130
- Product ID
- 21130-056_792e598a-eaee-4d0a-9c99-154ecbf29aaf
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Diphenhydramine Citrate, Ibuprofen
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Safeway, Inc.
- Application
- ANDA211404
- Marketing category
- ANDA
- Marketing start
- 2024-03-01
- Marketing end
- 2026-12-31
- Substance
- DIPHENHYDRAMINE CITRATE; IBUPROFEN
- Active strength
- 38; 200 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | DIPHENHYDRAMINE CITRATE; IBUPROFEN | 38MG;200MG | TABLET / ORAL | 2024-04-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | 8072bd15b7f6… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211404-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2024-04-11 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ibuprofen PM
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IBUPROFEN | 38 mg/1 |
| DIPHENHYDRAMINE CITRATE | 200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WK2XYI10QM | Internal UNII lookup |
| 4OD433S209 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 895664 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e49d1e9e-99a6-4d81-90d6-ef23a584a3d1 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 21130-056-40 | 2026-01-05 | Drug Facts |
| 21130-056-80 | 2026-01-05 | Drug Facts |
| 21130-056-40 | 2025-01-30 | Drug Facts |
| 21130-056-80 | 2025-01-30 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21130-056-40 | Ibuprofen PM | 1 in 1 BOX | TABLET, COATED | 1 | 7 | |
| 21130-056-40 | Ibuprofen PM | 40 in 1 BOTTLE, PLASTIC | TABLET, COATED | 40 | 7 | |
| 21130-056-80 | Ibuprofen PM | 80 in 1 BOTTLE, PLASTIC | TABLET, COATED | 80 | 7 | |
| 21130-056-80 | Ibuprofen PM | 1 in 1 BOX | TABLET, COATED | 1 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen PM | DIPHENHYDRAMINE CITRATE, IBUPROFEN | Safeway, Inc. | e49d1e9e-99a6-4d81-90d6-ef23a584a3d1 | 2026-01-05 | Warnings | 211404 ANDA211404 21130-056-40 21130-056 21130005640 |
| Ibuprofen PM | DIPHENHYDRAMINE CITRATE, IBUPROFEN | Family Dollar (FAMILY WELLNESS) | e01be0d7-e16d-44f1-9a0c-251ff9a65d28 | 2025-10-22 | Warnings | 211404 ANDA211404 |
| Ibuprofen PM | DIPHENHYDRAMINE CITRATE, IBUPROFEN | WR Group, Inc. | 1e2feaf0-7fff-43d5-bcfe-9f2851bdc805 | 2025-03-25 | Warnings | 211404 ANDA211404 |
| Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg | IBUPROFEN, DIPHENHYDRAMINE CITRATE | PLD Acquisitions LLC DBA Avma Pharma Solutions | a7d729bf-6d7a-415a-a414-cae0ba6d0063 | 2024-04-24 | Warnings | 211404 ANDA211404 |
| Ibuprofen PM | DIPHENHYDRAMINE CITRATE, IBUPROFEN | WALMART INC. (see also Equate) | d86151b6-d5c5-4d93-9cfd-43ab7ad0443a | 2024-04-15 | Warnings | 211404 ANDA211404 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 895664 | ibuprofen 200 MG / diphenhydrAMINE citrate 38 MG Oral Tablet | PSN | e49d1e9e-99a6-4d81-90d6-ef23a584a3d1 | 7 |
| 895664 | diphenhydramine citrate 38 MG / ibuprofen 200 MG Oral Tablet | SCD | e49d1e9e-99a6-4d81-90d6-ef23a584a3d1 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 21130-056-40 | 21130005640 | 1 BOTTLE, PLASTIC in 1 BOX (21130-056-40) / 40 TABLET, COATED in 1 BOTTLE, PLASTIC | 2024-03-01 | 2026-12-31 | No | No | Historical |